Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage
Objective: To evaluate the clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage.
Methods: One hundred and fifty-six patients with hypertensive cerebral hemorrhage were selected. They were randomly divided into the control group (78 cases) and observation group (78 cases). The control group was treated with conventional craniotomy evacuation of hematoma, while the observation group was treated with minimally invasive intracranial hematoma. Neurological impairment score, treatment efficacy and Barthel index were compared between two groups. Comparison results and clinical data of these patients were retrospectively analyzed.
Results: Neurological impairment score in observation group had a significantly obvious decrease compared to control group (p < 0.05). Curative effect of observation group was superior to control group and the difference was significant (p < 0.05). Average operation time in observation group (51.20±10.30 minutes) was much shorter than control group (108.60±12.80 minutes). Amount of hematoma cleared for the first time in control group (75.40±10.20 (%)) was more than observation group (45.10±8.70 (%)). Hematoma in observation group (3.90±0.80 days) disappeared faster than control group (5.80±0.90 days). Differences of the above indexes between two groups were all significant (p < 0.05). Moreover, Barthel index of observation group was much better than control group (p < 0.05).
Conclusion: Treating hypertensive cerebral hemorrhage with minimally invasive intracranial hematoma is remarkably effective. It should be promoted and practiced extensively.
How to cite this:Yang G, Shao G. Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage. Pak J Med Sci. 2016;32(3):677-681. doi: http://dx.doi.org/10.12669/pjms.323.9533
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- There are currently no refbacks.